{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:12Z","timestamp":1791341532026,"version":"4.3.1"},"posted":{"date-parts":[[2026,10,2]]},"group-title":"Health Informatics","reference-count":28,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,10,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among individuals with type 2 diabetes (T2D), yet accurate identification from electronic health records (EHRs) remains challenging because clinically relevant information is fragmented across structured data and unstructured clinical documentation. We developed a rule-based computable phenotype (CP) framework that integrates structured EHRs with clinical notes for scalable MASLD identification in patients with T2D. The framework comprises five complementary CP algorithms derived from validated fibrosis indices and liver injury biomarkers, together with a lightweight natural language processing module that identifies MASLD-related evidence using keyword matching, contextual filtering, and negation detection. The proposed framework was systematically evaluated across multiple threshold settings, with additional validation through age- and sex-stratified analyses and manual chart review. The findings demonstrate that integrating structured and unstructured EHR data provides an accurate and scalable framework for real-world MASLD phenotyping and offers a practical strategy for developing CPs for other chronic diseases.<\/jats:p>","DOI":"10.64898\/2026.09.26.26364078","type":"posted-content","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:10:20Z","timestamp":1790986220000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving MASLD Identification in Patients with T2D: A Computable Phenotype Framework Integrating Structured Data and Clinical Notes"],"prefix":"10.64898","author":[{"given":"Yuanhan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Electrical and Computer Engineering, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Mathematics, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1403-0396","authenticated-orcid":false,"given":"Rui","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026100619200891000_2026.09.26.26364078v1.1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026100619200891000_2026.09.26.26364078v1.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2026100619200891000_2026.09.26.26364078v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"2026100619200891000_2026.09.26.26364078v1.4","doi-asserted-by":"crossref","unstructured":"de Crecy CA , Yang Q , Liu M , Yin R , Sharma A. Low rates of MASLD screening in young adults with type 2 diabetes: A retrospective cohort study. J Endocr Soc. 2025 Dec 29;bvaf223.","DOI":"10.1210\/jendso\/bvaf223"},{"key":"2026100619200891000_2026.09.26.26364078v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.040"},{"key":"2026100619200891000_2026.09.26.26364078v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"2026100619200891000_2026.09.26.26364078v1.7","first-page":"808","article-title":"FCFNets: A factual and counterfactual learning framework for enhanced hepatic fibrosis prediction in young adults with T2D","volume":"2025","year":"2026","journal-title":"AMIA Annu Symp Proc"},{"key":"2026100619200891000_2026.09.26.26364078v1.8","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.15184"},{"issue":"111652","key":"2026100619200891000_2026.09.26.26364078v1.9","first-page":"111652","article-title":"Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population","volume":"211","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2026100619200891000_2026.09.26.26364078v1.10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/HEP.0000000000000913","article-title":"Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease","volume":"83","year":"2026","journal-title":"Hepatology"},{"key":"2026100619200891000_2026.09.26.26364078v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01045-z"},{"key":"2026100619200891000_2026.09.26.26364078v1.12","doi-asserted-by":"publisher","DOI":"10.13063\/2327-9214.1232"},{"issue":"104335","key":"2026100619200891000_2026.09.26.26364078v1.13","first-page":"104335","article-title":"Trends and opportunities in computable clinical phenotyping: A scoping review","volume":"140","year":"2023","journal-title":"J Biomed Inform"},{"key":"2026100619200891000_2026.09.26.26364078v1.14","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2013-001935"},{"key":"2026100619200891000_2026.09.26.26364078v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3208"},{"key":"2026100619200891000_2026.09.26.26364078v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2020.103526"},{"issue":"5","key":"2026100619200891000_2026.09.26.26364078v1.17","doi-asserted-by":"crossref","first-page":"100611","DOI":"10.1016\/j.gastha.2024.100611","article-title":"Clinical phenotypes may be able to identify populations with nonalcoholic fatty liver-spectrum disease","volume":"4","year":"2025","journal-title":"Gastro Hep Adv"},{"key":"2026100619200891000_2026.09.26.26364078v1.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3952-x"},{"key":"2026100619200891000_2026.09.26.26364078v1.19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"2026100619200891000_2026.09.26.26364078v1.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00006"},{"key":"2026100619200891000_2026.09.26.26364078v1.21","first-page":"91","article-title":"Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes","volume":"25","year":"2020","journal-title":"Pac Symp Biocomput"},{"key":"2026100619200891000_2026.09.26.26364078v1.22","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v8.i2.11"},{"key":"2026100619200891000_2026.09.26.26364078v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2025.102556"},{"key":"2026100619200891000_2026.09.26.26364078v1.24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496"},{"key":"2026100619200891000_2026.09.26.26364078v1.25","first-page":"774079","article-title":"MAFLD\/NAFLD biopsy-free scoring systems for hepatic steatosis, NASH, and fibrosis diagnosis","volume":"8","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026100619200891000_2026.09.26.26364078v1.26","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2009.001560"},{"key":"2026100619200891000_2026.09.26.26364078v1.27","doi-asserted-by":"publisher","DOI":"10.1006\/jbin.2001.1029"},{"key":"2026100619200891000_2026.09.26.26364078v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2009.05.002"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.26.26364078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:20:18Z","timestamp":1791339618000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.09.26.26364078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":28,"URL":"https:\/\/doi.org\/10.64898\/2026.09.26.26364078","relation":{},"subject":[],"published":{"date-parts":[[2026,10,2]]},"subtype":"preprint"}}